98%
921
2 minutes
20
Background And Aim: Cerebral malaria in Gambian children has been studied but there is limited information on CM in adults. The study assesses the clinical features and outcome of CM in adult patients admitted at the Edward Francis Small Teaching Hospital.
Method: This was a retrospective review of all adult patients with malaria admitted to the internal medicine department from October 18, 2020 to February 2, 2022.
Results: A total number of 319 adults were admitted with malaria. Eighty (25%) patients met the criteria for CM. The median age of the CM patients was 19 years. CM patients were younger ( < 0.001), more likely to be of the adolescent age group ( < 0.001), more likely to be referred from a lower-level health facility ( < 0.001), and more likely to be admitted in intensive care < 0.001) as compared to NSCM or UM patients. The total in-hospital mortality of CM patients was 23.8%. Ten (52.6%) out of the 19 patients died within the first 24 h of admission. In multivariate analysis, CM patients with acute kidney injury at presentation was an independent predictor of mortality in this study.
Conclusion: CM seems to affect the adolescent age group more than the older adults in The Gambia. The clinicians should be able to identify these high-risk patient group and institute prompt critical care interventions and/or treatment. The findings in this study also identify the need to expand access of critical care interventions and hemodialysis to help improve the prognosis of adult CM patients in The Gambia.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11752140 | PMC |
http://dx.doi.org/10.1002/hsr2.70401 | DOI Listing |
J Int Med Res
September 2025
Department for Pathology, Chongqing General Hospital, China.
This case details a male patient in his late 50s weighing 90 kg who traveled to Burkina Faso, Africa, for approximately 1 month. He developed fever, headache, and generalized myalgia 3 days after returning to Chongqing, China. The interval from the emergence of the patient's symptoms to the diagnosis of severe falciparum malaria and the commencement of artesunate treatment was 9 days.
View Article and Find Full Text PDFCureus
August 2025
Infectious Diseases, Qazvin University of Medical Sciences, Qazvin, IRN.
Malaria is a potentially life-threatening parasitic disease caused by a protozoal infection via Plasmodium species, transmitted by a carrier female Anopheles mosquito. Cerebral malaria is typically caused by Plasmodium falciparum and is known as a fatal neurological complication of malaria. This systematic review and meta-analysis was performed due to limited research on the comparison of artemether and quinine for the treatment of cerebral malaria in children.
View Article and Find Full Text PDFPLoS One
September 2025
Department of Medical Sciences, School of Medicine, Walailak University, Nakhon Si Thammarat, Thailand.
Cerebral malaria (CM), a life-threatening consequence of Plasmodium falciparum infection, is associated with a high fatality rate and long-term brain impairment in survivors. Despite advances in malaria treatment, effective therapies to mitigate the severe neurological consequences of CM remain limited. Consequently, novel antimalarial drugs with different mechanisms or neuroprotective advantages are urgently required.
View Article and Find Full Text PDFJ Neuroinflammation
August 2025
Department of Immunology, College of Basic Medical Sciences, China Medical University, Shenyang City, Liaoning Province, 110122, P.R. China.
Cerebral malaria (CM) is the most severe complication of Plasmodium falciparum infection, and accounts for the majority of malaria-associated mortality. Reducing the overwhelming inflammatory responses in the early stage of infection is a key point to prevent death due to CM. In this study, we found that neutrophil mobilization occurred rapidly in response to Plasmodium berghei ANKA (PbA) infection in a murine CM model.
View Article and Find Full Text PDF